OpenAI Healthcare United States

Paradigm

Document Processing

Paradigm needed to extract and interpret complex medical-record information for clinical-trial enrollment faster and more accurately so providers could match patients to trials without overwhelming clinicians with manual review.

90% reduction in expert clinician time needed for model validation
At least 10% more accurate than state-of-the-art ML models on a blended precision/recall metric
Potentially evaluates hundreds of patients per minute versus roughly 50 patients per day for a typical nurse research coordinator

Reported impact

Business outcome

Paradigm accelerated its product roadmap, reduced clinician validation effort, improved extraction accuracy, and created a path to more equitable access to life-saving clinical trials for underserved patients.

  • Compliance
  • Customer Experience
  • Productivity Improvement

Solution

Paradigm replaced a slow patchwork of specialized healthcare ML and NLP models with GPT-4 delivered through the OpenAI API to analyze clinical-trial data and patient records. Instead of building, training, and validating a separate model for every data element, the company now uses GPT-4’s long context and multimodal capabilities to summarize unstructured medical text, identify relevant clinical details, and match patients against trial criteria. The system was evaluated on expert-curated golden datasets and outperformed state-of-the-art domain models by at least 10% on a blended precision/recall metric, with especially strong gains on complex information spread across multiple documents. Because the resulting output requires far less validation data and less manual checking from clinicians, Paradigm can expand faster to new providers and trials while moving toward interactive patient-eligibility conversations that further reduce burden on nurses and doctors.

Data flow

Medical records, notes, and trial documents are passed through the OpenAI API to GPT-4, which extracts structured facts and eligibility signals from unstructured content. Paradigm then validates outputs against expert-curated datasets and uses the resulting matches to support clinicians and provider partners in enrollment workflows.

Solution architecture

2 components · 1 layer
  1. Compute
    • OpenAI API Provides the integration layer through which Paradigm processes medical records and trial data.
    • GPT-4 Extracts, interprets, and reasons over unstructured clinical data for trial matching and screening.

Architecture clues

  • Clinicians can eventually have a dialogue with ChatGPT about patient eligibility and missing information
  • GPT-4 performs especially well when information is spread across many unstructured documents
  • Paradigm selected OpenAI in part for multimodal entry, long context windows, and HIPAA-oriented compliance support
  • Previous approach required a separate ML model for every data element

Evidence from the source

"GPT‑4 was at least 10% more accurate than state-of-the-art ML models"
"Paradigm estimates that they only need 1/10th of the data to evaluate GPT‑4’s output"
"With GPT‑4, their platform can potentially evaluate hundreds of patients per minute"
"supporting our need to comply with HIPAA"
Transparency Evidence & methodology 95/100 reference value · 94% confidence · 3 sources

Review how this reference was scored and trace each normalized claim back to its documented source.

01

Scoring methodology

How scores are calculated

Customer Reference Value measures usefulness as a customer reference. Evidence Confidence measures the quality and traceability of available evidence, not independent verification.

Customer reference value95/100
  • Problem clarity20/20
    Measures whether the customer's operational problem is specific enough to compare.
  • Implementation depth25/25
    Rewards named components, data flow, integrations, and architecture detail.
  • Outcome specificity20/20
    Measures whether the reported benefit is concrete rather than a generic claim.
  • Quantified impact25/25
    3 metrics describe measurable impact.
  • Deployment scale5/10
    Rewards evidence of a live or scaled deployment and meaningful integration scope.
Evidence confidence94%
  • Source authority20/25
    The main evidence is an official vendor-published customer story.
  • Claim traceability25/25
    12 of 12 key fields link to a named source.
  • Direct evidence20/20
    4 direct source quotes retained.
  • Date provenance10/10
    The publication date comes from the source page or publisher.
  • Source transparency9/10
    3 source references document publisher, URL, authority, retrieval, and supported fields.
  • Implementation specificity10/10
    Rewards source-backed components, data flow, quantified impact, and a specific outcome.
02

Traceability

Sources & provenance

Field coverage shows which facts each source supports. Dates are shown only when documented by the source.

  1. OpenAI

    Paradigm customer story

    First-party
    https://openai.com/index/paradigm/
    Source type
    Vendor-published customer story
    Published
    Mar 18, 2024
    Supports
    • Customer
    • Business problem
    • Solution
    • Products
    • Solution components
    • Data flow
    • Integrations
    • technical area
    • use case category
    • Business outcome
    • outcome category
    • Metrics
    • Architecture
    • evidence quotes
    • Publication date
  2. Paradigm Health

    Paradigm Health | AI-Native Clinical Trial Platform for Sponsors and Providers

    First-party
    https://www.paradigmhealth.ai/

    The official site footer lists "175 S. 3rd St, Suite 1000, Columbus, OH 43215," which places the company in the United States.

    Source type
    Official company website
    Supports
    • Region
  3. Built In

    Paradigm Health Careers, Perks + Culture | Built In

    Independent secondary
    https://builtin.com/company/paradigm-health

    The Organization JSON-LD lists addressLocality 'Indianapolis', addressCountry 'US', and numberOfEmployees value 144.

    Source type
    Structured company profile
    Supports
    • Company size

Date evidence

  • Published on source page Mar 18, 2024 · OpenAI · First-party
    Open date source
Not separately sourced Industry. Treat these normalized attributes as lower-confidence until a dedicated source is added.